Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $250.9M
Liabilities Breakdown FY2020
Total Liabilities: $16.2M
Asset Breakdown
Total Assets: $250.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $242.2M | 96.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $134.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.6M | 3.4% |
Liabilities Breakdown
Total Liabilities: $16.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $732.0K | 4.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.5M | 95.5% |